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THE RELATIONSHIP BETWEEN ENDOGENOUS CREATINE LEVELS AND
MAXIMAL UPPER BODY STRENGTH, SHORT TERM MUSCLE RECOVERY AND
BODY FAT IN MALES
by
Vincent James Dalbo III
(Under the Direction of Jim McMillan)
ABSTRACT
Numerous studies have found creatine supplementation to positively enhance
performance but no research found has examined the effects of endogenous creatine
levels on performance. The purpose of this study was twofold. First we examined
correlations between endogenous creatine levels and strength, absolute strength, short
term muscle recovery and body fat. We also examined the effects of creatine
supplementation with a sufficient washout period on plasma creatinine levels.
Participants consisted of 24 healthy men who met with the experimenter twice over a 4
day period. Significant positive correlations (p ≤ .05) were found between creatine and
strength, absolute strength, lean body mass and muscle recovery as a function of total
weight lifted following 3 and 5 sets of the muscle fatigue protocol.
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CHAPTER 1
INTRODUCTION
Creatine is stored in the liver, brain, kidneys and testes (Persky & Brazeau, 2001)
but 95% (Balsom, Soderlund, & Ekblom, 2004; Grande & Graves, 2005) to 98% of
creatine is stored in skeletal muscle (Peeters, Lantz, & Mayhew, 1999) as creatine is
directly involved in muscular contractions (Grande & Graves, 2005). During creatine
supplementation total creatine content in muscle has been found to increase by 10%-20%
with 20%-40% of increased intramuscular creatine being stored as phosphocreatine
(Kreider, Ferreira, Wilson, Grindstaff, Plisk, Reinardy, et al., 1998). The increased
creatine content in muscles enhances the phosphagen system (Almada, Kreider, Ferreira,
Wilson, Grindstaff, Plisk, et al., 1997; Bosco, Tihanyi, Pucspk, Kovacs, Gobossy, Colli,
et al., 1997; Casey, Constantin-Teodosiu, Howell, Hultman, & Greenhaff, 1996; Earnest,
Snell, Rodriguez, Almada, & Mitchell, 1995; Ferreira, Kreider, Wilson, Grindstaff, Plisk,
Reinhardy, et al., 1997; Grindstaff, Kreider, Bishop, Wilson, Wood, Alexander, et al.,
1997; Harris, Viru, Greenhaff, & Hultman, 1993; Kirksey, Warren, Stone, Stone, &
Johnson, 1997; Kreider et al., 1998; Kreider, 1998; Prevost, Nelson, & Morris, 1997;
Rawson & Volek, 2003; Skare, Skadberg, & Wisnes, 2001) allowing users to maintain
higher levels of performance for longer durations of time.
Over 200 studies have been conducted examining the effects of creatine
supplementation on athletic performance since 1993 (Rawson & Volek, 2003) and in
2000 The American College of Sports Medicine (ACSM) released a position statement
claiming creatine supplementation can improve high intensity, short duration
performance especially during repeated exercise bouts (ACMS, 2000; Rawson & Volek;
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Terjung, Clarkson, Eichner, Greenhaff, Hespel, Israel, et al., 2000). However, not all
creatine supplementation studies have resulted in significant performance improvements
as it may be necessary to increase total muscle creatine by close to 20 mmol·kg-1 dry
weight (dw) from creatine supplementation to obtain significant performance
improvements (Greenhaff, Bodin, Soderlund, & Hultman, 1994). Research has identified
three interindividual responses to creatine supplementation: responders, individuals who
experience a > 20 mmol·kg-1 dw increase in total intramuscular creatine monohydrate
plus phosphorylated creatine (Greenhaff, Bodin, Soderlund, & Hultman; Syrotuik & Bell,
2004); quasi responders, individuals who experience between a 10-20 mmol·kg-1 dw
increase and nonresponders, individuals who experience < 10 mmol·kg-1 dw increase
(Syrotuik & Bell). It has been established that performance increases are correlated to the
amount of creatine that is absorbed during creatine supplementation (Syrotuik & Bell)
and this correlation is prominently displayed in vegetarians who have lower endogenous
creatine levels than non-vegetarians and have been found to tend to experience greater
benefits from creatine supplementation (Rae, Digney, McEwan, & Bates, 2003; Shrier,
2004).
Numerous studies have found creatine supplementation to increase muscular
strength (Greenhaff, Casey, Short, Harris, Soderlund, & Hultman, 1993; Balsom,
Soderlund, Sjodin, & Ekblom, 1995; Earnest, Snell, Rodriguez, Almada, & Mitchell,
1995; Rawson, Clarkson, Price, & Miles, 2002; Vandenberghe, Goris, Van Hecke, Van
Leemputte, Vangerven, & Hespel, 1997; Vandenberghe, Van Hecke, Van Leemputte,
Vanstapel, & Hespel, 1999), short term muscle recovery (Almada et al., 1997; Bemben &
Lamont, 2005; Bosco et al., 1997; Kreider, 1998) and fat-free mass (Becque, Lochmann,
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& Melrose, 1997; Becque, Lochmann, & Melrose, 2000; Earnest, Snell, Rodriguez,
Almada, & Mitchell, 1995; Haff, Kirsey, & Stone, 1999; Kreider et al., 1998; Kreider,
Grindstaff, Wood, Bullen, Klesges, & Lotz, 1996; Maganaris and Maughan, 1998;
Rawson, Clarkson, Price, & Miles, 2002; Vandenberge et al., 1997) but no research
found has examined the effects of endogenous creatine levels on performance or body
composition even though endogenous creatine levels normally range between 120-140 g
dry mass (dm) (Rawson & Volek, 2003; Sarubin-Fragakis), with studies finding
endogenous creatine levels ranging from 100-150 mmol/kg dm (Harris, Hultman, &
Norjedo, 1974; Steenge, Simpson, & Greenhaff, 2000).
The normal variability in endogenous creatine levels (20 g dm) is equivalent to
the proposed amount of creatine that must be absorbed during creatine supplementation
to obtain significant performance improvements. Therefore we expect endogenous
creatine levels to be positively correlated with strength, absolute strength determined by
subtracting body weight from one repetition maximum strength and short term muscle
recovery while being negatively correlated with body fat percentage. Additional analyses
were conducted to examine if past creatine supplementation followed by an appropriate
washout period of 4 months (Rawson, Persky, Price, & Clarkson, 2004) had an effect
creatinine levels; as it is unknown if new steady-state relations occur between creatine
and creatinine during periods of prolonged creatine supplementation (Culpepper, 1998).
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CHAPTER 2
METHODS
Participants
Each participant was required to be a student at Georgia Southern University and
had to have at least 1 year of resistance training experience (M = 4.80, SD = 3.03 years)
to reduce the effect of strength differences due to technique. Participants were also
required to bench press their body weight and could not have consumed an ergogenic aid
over the past 2 months or a creatine supplement in the previous 4 months. Data were
collected on 40 male participants but only 23 participants were included in the study.
Participants were eliminated because of suspected creatine supplementation (1), blood
lysing (2) during the blood draw which negatively affected the accuracy of the creatinine
reading. Resistance training during the course of the study (1), failure to meet the strength
requirement (2), consuming a creatine supplement (2), consuming an ergogenic aid (4)
and (5) failing to return the food log. Each participant was informed of the procedures
involved in the study along with the risks and benefits of participation. Informed consent
was obtained after approval from the Institutional Review Board.
Procedures
Participants met with the experimenter twice during a four day period. During the
first meeting participants read and signed the informed consent (see Appendix C) and
were instructed how to record a three day food diary (see Appendix D). Nutritional data
were recorded to ensure no significant changes in energy or macronutrient consumption
occurred between participants over the duration of the study. Data were analyzed using
Diet Analysis Plus (7.0, DA PLUS). Next, participants completed a demographic
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questionnaire that contained questions assessing the use of ergogenic aids, current
physical activity level and weight training experience (see Appendix E). Then the
experimenter demonstrated and described proper bench press technique to each
participant using the standards described by the National Strength and Conditioning
Association (NSCA) (Baechle & Earle, 2000, see Appendix F). Participants then
practiced bench press technique for 2 sets of 5 repetitions with approximately 50% of
their bodyweight. Participants were then reminded to refrain from resistance training for
the duration of the study and to fast for 8 hours prior to the next meeting with the
experimenter.
Three days later, during the second meeting, participants returned their 3 day food
log. Next height, weight and body fat percentage (using the 3-site Jackson Pollack
skinfold equation) (Jackson & Pollack, 1985, see Appendix G) of each participant were
recorded followed by a 10 mL blood draw from the left antecubital vein by a registered
nurse. Blood was collected in a Vacutainer Glass Whole Blood Tube with heparin (Mfr.
No.: 366535, Fisher Scientific, St. Louis, MO), centrifuged and pipetted to separate the
plasma from the blood and the plasma was frozen for later analysis. Participants were
then tested for strength using procedures set forth by the NSCA (Baechle & Earle, 2000,
see Appendix H). Five minutes following completion of the one repetition maximum test
participants performed five bench press sets to failure with 80% of their one repetition
maximum with two minute rest periods between sets to determine the correlation between
endogenous creatine levels and short term muscle recovery. Participants were verbally
encouraged to give maximal effort during each lift.
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Creatine Determination
The body surface area of each participant was calculated (see Figure 1), divided
by 1.73 m2 and multiplied by 120 g giving an estimate of endogenous creatine levels.
(Delanghe, De Slypere, De Buyzere, Robbrecht, Wieme, & Vermeulen, 1989).

Figure 1. Calculation of body surface area (BSA)
________________________________________________________________________
BSA = ((body weight x height) / 3125)1/2
Body weight in pounds
Height in inches
BSA is calculated in square meters
________________________________________________________________________

Creatinine Determination
Blood samples were centrifuged (MARATHON 21 K/R, Fisher Scientific, St.
Louis, MO) at 850 x g for 10 minutes at 4 degrees Celsius. Then plasma was pipetted
from the Vacutainer into 2 separate vials and immediately frozen at -80 degrees Celsius
for later analysis using a creatinine kit (500701 from Cayman Chemical Company, Ann
Arbor, MI). For creatinine determination plasma samples were thawed at room
temperature (~74 degrees Celsius) and 8 standards were prepared by mixing the
creatinine standard with HPLC-grade water. Next plasma samples were placed on a
Votex mixer and 15 µl of the creatinine sample were pipeted into three wells using a
multichannel adjustable volume micropipette (Finnpipett, Thermo electron Corporation,
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Waltham, MA). A new pipette tip was used for each sample during each step of the
procedure. Then the reaction was started by adding 150 µl of an alkaline picrate solution
and the plate containing the samples was covered with a plate cover and mixed on an
orbital shaker (Maxi Mix II, Type 37600 Mixer, Barnstead/Thermolynce, Dubuque, IA)
for 10 minutes at a low speed. The plate cover was removed and the samples were gently
blown on to pop excess bubbles. Initial absorbance values were read at 492 nm on a plate
reader (Spectromax 340, SOFTmaxPro 2.6.1, Sunnyvale, CA). The plate was removed
from the plate reader and 5 µl of acid solution was added to each well. The plate was
covered with the plate cover and mixed on an orbital shaker for 20 minutes at a low
speed. The plate cover was removed and the samples were gently blown on to pop excess
bubbles. Final absorbance values were read at 492 nm on a plate reader. For the extended
creatinine analysis see Appendix I.
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CHAPTER 3
RESULTS
Plasma creatinine levels were determined in triplicate (M = 1.152, SD = .267
mg/dl) with an intraclass correlation coefficient of r = .947. Endogenous creatine levels
were found to be significantly (p ≤ .05) positively correlated with strength (r = .797,
p < 0.001) and absolute strength (r = .456, p = 0.029). Endogenous creatine levels were
not found to be correlated with short term muscle recovery when examining total
repetitions after three (r = -.144, p = 0.512) or five sets (r = -.124, p = 0.574); however,
when examining the correlation between endogenous creatine levels and total weight
lifted (weight lifted x repetitions) as a measure of short term muscle recovery significant
positive correlations were found after three sets (r = .503, p = 0.014) and five sets
(r = .522, p = 0.011). Endogenous creatine levels were not found to be correlated with
body fat percentage (r = .292, p = 0.177) but were significantly positively correlated with
lean body mass (r = .524, p = 0.010). Additional significant correlations were found
between creatine and height (r = .876, p < 0.001), weight (r = .989, p < 0.001), years of
resistance training (r = .701, p < 0.001) and current amount of repetitions performed
while resistance training (r = -.683, p = 0.003).
Results from independent t-tests revealed participants who previously used a
creatine supplement to have significantly (p = 0.005) higher endogenous creatine levels
than participants who never used a creatine supplement. Additionally those who had used
a creatine supplement had significantly more resistance training experience (p = 0.002)
weighed more (p = 0.004) and had a higher body fat percentage (p = 0.001) than
participants who have never used a creatine supplement. Moreover no difference in
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creatinine levels were found between participants who had and had not consumed a
creatine supplement (p = .941). For descriptive statistics see Table 1.

Table 1
Participant Descriptive Statistics
Descriptive Statistics

M

SD

Age

20.91

3.04 years

Height

68.61

2.59 inches

Body Weight (BW)

172.57

20.30 pounds

Body Fat Percentage

13.14

5.75 %

Lean Body Mass

152.57

12.15 pounds

1 Repetition Maximum (RM)

222.61

40.73 pounds

Absolute Strength (1RM – BW)

50.04

27.13 pounds

Repetitions Set 1 (80% 1 RM)

6.43

1.80 reps

Repetitions Set 2 (80% 1 RM)

4.35

1.07 reps

Repetitions Set 3 (80% 1 RM)

3.13

1.01 reps

Repetitions Set 4 (80% 1 RM)

2.43

0.66 reps

Repetitions Set 5 (80% 1 RM)

2.22

0.60 reps

Total Repetitions (Three Sets)

13.91

3.07 reps

Total Repetitions (Five Sets)

18.57

3.92 reps

Calorie Consumption

2737.82

913.08 calories

Protein Consumption

114.75

43.22 grams
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CHAPTER 4
DISCUSSION
The majority of research has found creatine supplementation to increase strength,
muscle recovery and fat free mass with the most recent research finding a positive
relationship between the amount of creatine absorbed from creatine supplementation and
performance improvements (Greenhaff, Bodin, Soderlund, & Hultman, 1994, Syrotuik &
Bell, 2004). Interindividual differences in endogenous creatine levels have been found to
vary as much as 50 g so it is reasonable to believe endogenous creatine levels could effect
strength, short term muscle recovery and fat free mass as much as creatine
supplementation.
Endogenous Creatine and Strength
Bench press was used to assess strength because the majority of creatine
supplementation studies have measured strength using bench press or leg press
performance. Endogenous creatine levels were found to be significantly correlated with
strength and absolute strength. The correlation between endogenous creatine levels and
absolute strength is particularly important because strength has been found to be related
to body weight and body weight has been found to be correlated with creatine (Mosteller,
1987). Absolute strength negated the effects of body weight on strength by subtracting
each participants body weight from the amount of weight lifted. Arciero, Hannibal,
Nindl, Gentile, Hamed and Vukovich (2001) found 40% of increases in strength during
creatine supplementation occur independent of exercise and the results from this study
suggest that 63.5% of variance in upper body strength can be accounted for by
endogenous creatine levels.
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Endogenous Creatine and Short Term Muscle Recovery
The primary effect of creatine supplementation is to enhance the phosphagen
system (Almada et al., 1997; Bosco et al., 1997; Casey, Constantin-Teodosiu, Howell,
Hultman, & Greenhaff, 1996; Earnest, Snell, Rodriguez, Almada, & Mitchell, 1995;
Ferreira et al., 1997; Grindstaff et al., 1997; Harris, Viru, Greenhaff, & Hultman, 1993;
Kirksey, Warren, Stone, Stone, & Johnson, 1997; Kreider et al., 1998; Kreider, 1998;
Prevost, Nelson, & Morris, 1997; Rawson & Volek; Skare, Skadberg, & Wisnes, 2001)
by increasing total creatine content in muscles (Kreider et al., 1998) allowing users to
train harder for longer durations of time (Rawson & Volek, 2003). This study mimicked a
muscle fatigue protocol used by Kelly and Jenkins (1998). When using total repetitions
performed after three sets and five sets no significant correlations were found between
endogenous creatine and short term muscle recovery, most likely a function of
participants with higher creatine levels lifting significantly heaver weights. When
examining short term muscle recovery as a function of the total amount of weight lifted a
statistically significant correlation was found between creatine and short term muscle
recovery because participants with higher endogenous creatine levels were lifting greater
amounts of weight for the same amount of repetitions.
Endogenous Creatine and Fat Free Mass
The majority of research has found creatine supplementation to positively
influence body mass as studies have found creatine supplementation to increase fat free
mass (Becque, Lochmann, & Melrose, 1997; Becque, Lochmann, & Melrose, 2000;
Earnest, Snell, Rodriguez, Almada, & Mitchell, 1995; Haff, Kirsey, & Stone, 1999;
Kreider et al., 1998; Kreider, Grindstaff, Wood, Bullen, Klesges, & Lotz, 1996;
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Maganaris & Maughan, 1998; Rawson, Clarkson, Price, & Miles, 2002; Vandenberge et
al., 1997) and lean body mass (Flisinska-Bojanowska, 1996; Haff, Kirksey, & Stone;
Kirksey, Stone, Warren, Johnson, Stone, et al., 1999; Maganaris & Maughan, 1998;
Rawson, Clarkson, Price, & Miles; Noonan, Berg, Latin, Wagner, & Reimers, 1998;
Vandenberge et al., 1997) but a few studies have not found creatine supplementation to
have a statistically significant effect on body fat percentage (Kirksey et al. 1997; Noonan,
Berg, Latin, Wagner, & Reimers). Results from this study were equivocal in regard to the
effects of endogenous creatine levels on body mass as no statistically significant
correlation was found between endogenous creatine levels and body fat percentage, but
endogenous creatine levels were found to be significantly positively correlated with lean
body mass.
Creatine and Creatinine
A concern surrounding long term creatine supplementation is that a new steady
state relation between creatine and creatinine may develop (Culpepper, 1998), however
results from this study were consistent with prior research (Culpepper; Hultman,
Soderlund, Timmons, Cederblad, & Greenhaff, 1996; Poortmans, Auquier, Renaut,
Durussel, Saugy, & Brisson, 1997) which have suggested plasma creatinine levels to be
unaffected by short term creatine supplementation. Future research should focus on the
effects of long term creatine supplementation on creatinine levels as the possibility of
new steady state relations forming between creatine and creatinine following long term
creatine supplementation appears to be the last known disproved danger of long term
creatine supplementation. Researchers could also examine the effects of endogenous
creatine levels on aerobic performance as creatine supplementation has been found to
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enhance some forms of aerobic exercise (Birch, Nobel, & Greenhaff, 1994; Peyrebrune,
Nevill, & Donaldson, 1998) or the effects of caffeine on endogenous creatine levels as
caffeine appears to negate the positive effects of creatine supplementation
(Vandenberghe, Gillis, Van Leemputte, Van Hecke, Vanstaple, & Hespel, 1996). A
replication of the current study is also noteworthy as the sample size was small and with a
larger number of participants stronger correlations can be expected.
Additional Analysis
Strong significant positive correlations were found between creatine and height
and weight which is consistent with the work of Mosteller (1987) who found endogenous
creatine levels to be significantly correlated with body surface area. Endogenous creatine
levels were also found to be positively correlated with years of resistance training which
is expected as creatine has been found to be correlated with muscle mass (Culpepper,
1998). Endogenous creatine was also found to be negatively correlated with the amount
of repetitions performed while resistance training.

23
REFERENCES
ACSM (2000). Physiological and health effects of oral creatine supplementation.
Medicine & Science In Sports & Exercise, 32(3), 706-717.
Almada, A., Kreider, R., Ferreira, M., Wilson, M., Grindstaff, P., Plisk, S., et al. (1997).
Effects of calcium-HMB supplementation with or without creatine during training
on strength and sprint capacity. Federation of American Societies for
Experimental Biology, 11, 374.
Arciero, P. J., Hannibal, N. S., Nindl, B. C., Gentile, C. L., Hamed, J., & Vukovich,
M. D. (2001). Comparison of creatine ingestion and resistance training on energy
expenditure and limb blood flow. Metabolism, 50, 1429-1434.
Baechle, T. R., & Earle, R. W. (2000). Essential of strength training and conditioning
(2nd ed.). Champaign: National Strength and Conditioning Association.
Balsom, P. D., Soderlund, K., & Ekblom, B (1994). Creatine in humans with special
reference to creatine supplementation. Sports Medicine, 18, 268-280.
Balsom, P. D., Soderlund, K., Sjodin, B., & Ekblom, B. (1995). Skeletal muscle
metabolism during short duration high-intensity exercise: influence of creatine
supplementation. Acta Physiologica Scandinavica, 154, 303-310.
Baechle, T. R., & Earle, R. W. (2000). Essential of strength training and conditioning
(2nd ed.). Champaign: National Strength and Conditioning Association.
Becque, B., Lochmann, J., & Melrose, D. (1997). Effect of creatine supplementation
during strength training on 1 RM and body composition. Medicine & Science In
Sports & Exercise, 29(5), Supplement:146.

24
Becque, M. D., Lochmann, J. D., & Melrose, D. R. (2000). Effects of oral creatine
supplementation on muscular strength and body composition. Medicine & Science
In Sports & Exercise, 32, 654-658.
Bemben M. G., & Lamont H. S. (2005). Creatine supplementation and exercise
performance: recent findings. Sports Medicine, 35(2), 107-125.
Birch, R., Nobel, D., & Greenhaff, P. L. (1994). The influence of dietary creatine
supplementation on performance during repeated bouts of maximal isokinetic
cycling in man. European Journal of Applied Physiology, 69, 268-270.
Bosco, C., Tihanyi J., Pucspk, J., Kovacs, J., Gabossy, A., Colli, R., et al. (1997). Effects
of oral creatine supplementation on jumping and running performance.
International Journal of Sports Medicine, 18, 369-372.
Casey, A., Constantin-Teodosiu, D., Howell, S., Hultman, E, & Greenhaff, P. L. (1996).
Creatine ingestion favorably affects performance and muscle metabolism during
maximal exercise in humans. American Journal of Physiology, 271, 31-37.
Culpepper, M. R. (1998). Creatine supplementation: Safe as steak? Southern Medical
Journal. 91(9), 890-892.
Delanghe, J, De Slypere, J. P., De Buyzere, M., Robbrecht, J., Wieme, R., & Vermeulen,
A. (1989). Normal reference values for creatine, creatinine, and carnitine are
lower in vegetarians. Clinical Chemistry, 35, 1802-1803.
Earnest, C. P., Snell, P. G., Rodriguez, J., Almada, A. L., & Mitchell, T. L. (1995). The
effects of creatine monohydrate ingestion on anaerobic power indices, muscular
strength and body composition. Acta Physiologica Scandinavica, 153, 207-209.

25
Ferreira, M., Kreider, R., Wilson, M., Grindstaff, P., Plisk, S., Reinhardy, J., et al. (1997).
Effects of ingesting a supplement to enhance creatine uptake on strength and
sprint capacity. Medicine & Science in Sports & Exercise, 29(5), Supplement:
146.
Flisinska-Bojanowska, A. (1996). Effect of oral creatine supplementation on skeletal
muscle protein and creatine levels. Biology of Sport, 13, 39-46.
Grande, B. M., & Graves, S. B. (2005). Creatine supplementation: Forms, function, and
effects. Strength and Conditioning Journal, 27(1), 62-68.
Greenhaff, P. L., Bodin, K., Soderlund, K., & Hultman, E. (1994). Effect of oral creatine
supplementation on skeletal muscle phosphocreatine resynthesis. American
Journal of Physiology, 266, 730-745.
Greenhaff, P. L., Casey, A., Short, A. H., Harris, R., Soderlund, K, & Hultman, E. (1993).
Influence of oral creatine supplementation of muscle torque during repeated bouts
of maximal voluntary exercise in man. Clinical Science (Colch), 84, 565-571.
Grindstaff, P., Kreider, R., Bishop, R., Wilson, M., Wood, L., Alexander, C., et al.
(1997). Effects of creatine supplementation on repetitive sprint performance and
body composition in competitive swimmers. International Journal of Sport
Nutrition, 7, 330-346.
Haff, G. H., Kirksey, B. K., & Stone, M. H. (1999). Creatine supplementation. Strength
and Conditioning Journal, 21(4), 13-23.
Harris, R. C., Hultman, E., & Norjeso, L. O. (1974). Glycogen, glycolytic, intermediates
and high-energy phosphates determined in biopsy samples of the musculus

26
quadriceps of man at rest. Methods and variance of values. Scandinavian Journal
of Clinical and Laboratory Investigation, 33, 109-120.
Harris, R., Viru, M., Greenhaff, P., & Hultman, E. (1993). The effect of oral creatine
supplementation on running performance during short term exercise in man.
Journal of Physiology, 467, 74.
Hultman, E. Soderlund, K., Timmons, J. A., Cederblad, G., & Greenhaff, P. L. (1996).
Muscle creatine loading in men. Journal of Applied Physiology, 81(1), 232-237.
Jackson, A.S., & M.L. Pollack. Practical Assessment of body composition. Physician
Sport Medicine, 13:76-90, 1985. (As published in: Nieman DC: The Sports
Medicine Fitness Course. Bull Publishers. Palo Alto, 1986, pp. 101.
Kelly, V. G., & Jenkins, D. G. (1998). Effect of oral creatine supplementation on
near-maximal strength and repeated sets of high-intensity bench press exercise.
Journal of Strength and Conditioning Research, 12(2), 109-115.
Kirksey, B., Stone, M. H., Warren, B. J., Johnson, R. L., Stone, M., Haff, G. G., et al.
(1999). The effects of six weeks of creatine monohydrate supplementation on
performance measures and body composition in collegiate track and field athletes.
Journal of Strength and Conditioning Research, 13(2), 148-156.
Kirksey, K. B., Warren, B. J., Stone, M. H., Stone, M. R., & Johnson, R L. (1997). The
effects of six weeks of creatine monohydrate supplementation in male and female
track athletes. Medicine & Science in Sports & Exercise, 29, Supplement: 145.
Kreider, R. B., Ferreira, M., Wilson, M., Grindstaff, P., Plisk, S., & Reinardy, J., et al.
(1998). Effects of creatine supplementation on body composition, strength, and
sprint performance. Medicine & Exercise In Sports & Science, 30, 73-82.

27
Kreider, R., Grindstaff, P., Wood, L., Bullen, D., Klesges, R., & Lotz, D. (1996). Effects
of ingesting a lean mass promoting supplement during resistance training on
isokinetic performance. Medicine & Science In Sports & Exercise, 28,
Supplement:36.
Kreider, R. B. (1998). Creatine, the next ergogenic supplement? Sportsciecne Training &
Technology. Internet Society for Sport Science.
http://www.sportsci.org/traintech/creatine/rbk.html.
Maganaris, C. N., & Maughan, R. J. (1998). Creatine supplementation enhances
maximum voluntary isometric force and endurance capacity in resistance trained
men. Acta Physiologica Scandinavica, 163, 279-287.
Mosteller, R. D. (1987). Simplified calculation of body-surface area. New England
Journal of Medicine, 317(17), 1098.
Noonan, D., Berg, K., Latin, R. W., Wagner, J. C., & Reimers, K. (1998). Effects of
varying dosages of oral creatine relative to fat free body mass on strength and
body composition. Journal of Strength and Conditioning Research, 12, 104-108.
Peeters, B. M., Lantz, C. D., Mayhew, J. L. (1999). Effects of oral creatine monohydrate
and creatine phosphate supplementation on maximal strength indices, body
composition, and blood pressure. The Journal of Strength and Conditioning
Research, 13(1), 3-9.
Persky, A. M., & Brazeau, G. A. (2001). Clinical pharmacology of the dietary
supplement creatine monohydrate. Pharmacological Reviews, 53(2), 161-176.

28
Peyrebrune, M. C., Nevill, M. E., & Donaldson, F. J. (1998). The effects of oral creatine
supplementation on performance in single and repeated sprint swimming.
Journal of Sports Science, 16, 271-279.
Poortmans, J. R., Auquier, H., Renaut, V., Durussel, A., Saugy, M., & Brisson, G. R.
(1997). Effect of short-term creatine supplementation on renal responses in men.
European Journal of Applied Physiology, 76, 566-567.
Prevost, M. C., Nelson, A. G., & Morris, G. S. (1997). Creatine supplementation
enhances intermittent work performance. Research Quarterly for Exercise and
Sport, 68, 233-240.
Rawson, E. S., Clarkson, P. M., Price, T. B., & Miles, M. P. (2002). Differential response
of muscle phosphocreatine to creatine supplementation in young and old subjects.
Acta Physiologica Scandinavica, 174, 57-65.
Rawson, E. S., Persky, A. M., Price, T. B., & Clarkson, P. M. (2004). Effects of repeated
creatine supplementation on muscle, plasma, and urine creatine levels. Journal of
Strength and Conditioning Research, 18(1), 162-167.
Rawson, E. S., & Volek, J. S. (2003). Effects of creatine supplementation and resistance
training on muscle strength and weightlifting performance. Journal of Strength
and Conditioning Research, 17, 822-831.
Sarubin-Fragakis, A. (2000). The health professional’s guide to popular dietary
supplements Chicago: American Dietetic Association.
Shrier, I. (2004). Effect of creatine ingestion after exercise on muscle thickness in males
and females. Medicine & Science in Sports & Exercise, 36(10), 1832.

29
Skare, O. C., Skadberg, O., & Wisnes, A. R. (2001). Creatine supplementation improves
sprint performance in male sprinters. Scandinavian Journal of Medicine and
Science in Sports, 11, 96-102.
Steenge, G. R., Simpson, E. J., & Greenhaff, P. L. (2000). Protein- and
carbohydrate-induced augmentation of whole body creatine retention in humans.
Journal of Applied Physiology, 89(3), 1165-1171.
Syrotuik, D. G., & Bell, J. B. (2004). Acute creatine monohydrate supplementation: A
descriptive physiological profile of responders vs. nonresponders. The Journal of
Strength and Conditioning Research, 18(3), 610-617.
Terjung, R. L., Clarkson, P. Eichner, E. R., Greenhaff, P. L., Hespel, P. J., Israel, R. G.,
et al. (2000). American College of Sports Medicine Roundtable. The
physiological and health effects of oral creatine supplementation. Medicine &
Science In Sports & Exercise, 32, 706-717.
Vandenberghe, K., Gillis, N., Van Leemputte, M., Van Hecke, F., Vanstapel, & Hespel,
P. (1996). Caffeine counteracts the ergogenic action of muscle creatine loading.
Journal of Applied Physiology, 80, 452-457.
Vandenberghe, K., Goris, M., Van Hecke, P., Van Leemputte, M., Vangerven, L., &
Hespel, P. (1997). Long-term creatine intake is beneficial to muscle performance
during resistance training. Journal of Applied Physiology, 83, 2055-2063.
Vandenberge, K., Van Hecke, P., Van Leemputte, M., Vanstapel, F., Hespel, P. (1999).
Phosphocreatine resynthesis is not affected by creatine loading. Medicine &
Science In Sports & Exercise, 31, 236-242.

30
APPENDIX A: RESEARCH HYPOTHESES AND STUDY LIMITATIONS

31
Research Hypotheses
Endogenous creatine levels will be significantly positively correlated with upper body
strength (α ≤ .05), absolute strength (α ≤ .05) and muscle recovery (α ≤ .05) while being
negatively correlated to body fat percentage (α ≤ .05). Participants with the highest
endogenous creatine levels will have the highest one repetition maximum bench press
lifts relative to body mass, will recover quicker between sets and have low body fat
percentages than participants with lower endogenous creatine levels.

Limitations
The study was limited by the following:
-

Not a random sample.

Delimitations
The study was delimited to the following:
-

All participants were male students from Georgia Southern University.

-

The only exercise used to assess strength and muscle recovery was the bench
press.

-

All participants had at least one year weight training experience.

Assumptions of the Study
The conduct of this study was based upon the following assumptions:
-

Sample was representative of the population.
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-

Observations were drawn from normally distributed populations in regards to
endogenous creatine levels.

-

Observations represented random samples from other populations.

-

Participants had at least one year resistance training experience.

-

Participants gave maximal effort during study.

-

Measures of each participant’s creatine levels were accurate.

-

Participants did not consume an ergogenic aid within two months of the study.

-

Participants did not consume a creatine supplement within four months of the
study.

-

Received an accurate measure of each participant’s one repetition maximum
on bench press.

-

The experimenter was able to consistently identify improper technique.

-

Participants properly prepared themselves for testing, getting appropriate
amounts of sleep and eating properly before the test.

-

Participants accurately recorded their dietary intake.

Definition of Terms
-

Absolute Strength- Maximal one repetition maximum strength minus body
weight.

-

Failure- The inability to perform a repetition with proper bench press
technique as defined by the NSCA.

- Short term muscle recovery- Will be calculated as the total number of
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repetitions performed after five sets of a muscle fatigue protocol similar to
that used by Kelly and Jenkins (1998).
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Review of Literature
Effects of Hormones on Endogenous Creatine Levels
In humans endogenous creatine (Cr) levels achieve homeostasis at approximately
125 g (range 120 g -140 g) (Sarubin-Fragakis, 2000) which is significantly less Cr than
the body is capable of storing as Cr levels have been found to reach 195.1 mmol/kg dry
mass following 5 days of Cr/carbohydrate supplementation at a dose of 20 g per day
(Green, Hultman, Macdonald, Sewell, & Greenhaff, 1996). Endogenous Cr levels may be
maintained at significantly lower levels than maximal storage because of the importance
of arginine, glycine and methionine in the production of proteins and other cell
constituents such as keratin, ATP, DNA, RNA, GTP, methionine, histones, carnosine and
norepinephrine (Walker, 1979). Additionally the body appears to have developed
separate organs for the biosynthesis and utilization of Cr, as tissues responsible for Cr
biosynthesis do not significantly phosphorylate Cr and the organs responsible for Cr
biosynthesis do not contain significant amounts of creatine kinase (CK) which is used to
break down Cr into a usable form of energy. Furthermore mitochondria have been found
to contain either CK or amidinotransferase which is used in Cr production (Walker). The
separation of Cr production and utilization has several advantages. First the liver contains
the enzymes necessary to process dietary components that can be used in endogenous Cr
production before releasing the nutrients into the blood. Moreover the liver can produce
Cr from compounds released from muscle and nervous tissues and can slow its
metabolism through hormonal signals which is beneficial during periods of nutritional
constraints (Walker).
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Cr production is most efficient with optimal blood concentrations of insulin,
somatotropin, thyroid hormone and testosterone (Walker, 1979). Insulin and
glucocorticoids specifically effect Cr retention and excretion as insulin has been shown to
enhance Cr uptake in muscle while glucocorticoids have been found to increase plasma
Cr. Glucocorticoids are particularly important during dietary deficiencies and muscle
wasting diseases which increase the breakdown of muscle proteins resulting in increased
levels of amino acids in the liver. Increased levels or arginine and glycine in conjunction
with decreased protein synthesis promote Cr biosynthesis (Walker).
Creatine and Phosphocreatine
During high-intensity, short-duration bouts of exercise lasting approximately 1-14
seconds the phosphagen system is the primary energy supplier allowing the body to
function. Cr plays an essential role in the formation of ATP in the phosphagen system
(Powers & Howley, 2004) and ATP facilitates the phosphorylation of Cr (Walker, 1979).
As stored ATP begins to be synthesized for movement, phosphocreatine (PCr) initiates
the process of producing ATP in an attempt to keep ATP levels high. PCr is catalyzed by
CK to yield Cr, Pi (inorganic phosphate) and energy (ATP) (Powers & Howley). The
energy from this endergonic reaction is used in an exergonic reaction to combine ADP
with Pi to yield ATP (Haff, Kirksey, & Stone, 1999; Powers & Howley; Volek &
Kraemer, 1996). For movement ATP must be broken down by CK (ATPase) to produce
ADP, Pi and energy (Powers & Howley). Since the phosphagen system relies on PC for
the production of ATP, as PC levels decline performance decreases because of a
decreased amount of ATP being supplied to working muscles (Powers & Howley).
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During strenuous exercise the phosphocreatine energy shuttle acts in contracting
muscles to regenerate ATP through the return of high-energy phosphate bonds from the
PCr reserve to produce ATP (Culpepper, 1998). To keep the energy pathway (CK
reaction) running in a cyclic manner Cr is resynthesized into PCr by other energy
pathways, currently believed to be oxidative metabolism in the mitochondria (Haff,
Kirksey, & Stone, 1999). When the oxidative production of ATP exceeds energy needs
the high-energy phosphate bond of ATP is transferred to Cr to produce PCr in the
mitochondrial membrane.
The phosphocreatine energy shuttle can be described in three stages: the
peripheral terminus, the intervening space and the energy-generating terminus. The
phosphocreatine energy shuttle begins at the peripheral terminus which is the site of
energy utilization and is where isoenzymes of CK rephosphorylate ADP produced via the
CK reaction allowing muscular contractions. Cr that is produced from the CK reaction
travels across sites of energy production and utilization known as the intervening space.
Then Cr transverses in the intervening space and arrives in the energy-generating
terminus where Cr interacts with isoenzymes of CK to yield PCr from mitochondrial
ATP. Next regenerated PCr is shuttled back to sites of energy utilization and the process
of energy production continues.
ATP is the primary energy source for the body but PCr has a phosphate group
transfer potential approximately 3 kcal/mol higher than ATP (Walker, 1979) and
PCr/ATP ratios have been found to vary from 3:1 to 4:1 while PCr/Cr ratios have been
reported to range from 2:1 to 2.5:1 (Culpepper; 1998; Greenhaff, 1995; Hultman,
Soderlund, Timmons, Cederblad, & Greenhaff, 1996). Greater quantities of PCr and Cr
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are stored in favor of ATP because Cr and PCr have a lighter mass and are less negatively
charged than ATP and ADP which enables greater amounts to be stored in cells without
disrupting ionic and osmotic balances (Grande & Graves, 2005). Cr and PCr also act as
energy messengers making each less vulnerable to enzymatic diversion then ATP
(Walker). ATP and ADP are substrates to hundreds of enzymes while Cr and PCr are
substrates to only CK which emphasizes the importance of PCr and Cr for providing the
body with a constant energy source for smooth skeletal muscle contractions which allows
the heart to pump (Walker) and serves as an energy source for the brain (Rae, Dingney,
McEway, & Bates, 2003; Wallimann, Wyss, Brdiczka, Nicolay, & Eppenberger, 1992;
Norwood, Ingwall, Norwood, & Fossel, 1983).
Cr was first used commercially to promote growth and increase the energy of
chickens (Walker, 1979) and until the 1960s Cr had to be extracted from raw meat
(Grande & Graves, 2005). The synthetic production of Cr made the substance widely
available to the general population and in a matter of a few decades Cr became the most
popular athletic supplement (Grande & Graves) with sales nearing 100 million dollars in
1998 (Haff, Kirksey, & Stone, 1999) and exceeding 400 million dollars in 2004 (Grande
& Graves).
Positive Benefits of Cr Supplementation
In addition to being used as an ergogenic aid Cr supplementation has been found
to have positive effects on general health and has been used in the treatment of muscle
wasting diseases (Tarnopolsky, Roy, & MacDonald, 1997). Cr has been used in the
treatment of gyrate atrophy of the choroid retina (Sipila, Rapola, Simell, & Vannas,
1981) and has been found to enhance muscle functional capacity along with aerobic and
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anaerobic performance in people with various forms of neuromuscular diseases
(Tarnopolsky & Martin, 1999; Walter, Lochmuller, Reilich, Klopstock, Huber, Hartard,
et al., 2000) and McArdle’s disease (Vorgerd, Zange, Kley, Grehl, Husing, Jager, et al.,
2000). Incidentally many muscle wasting diseases are associated with irregularities in Cr
metabolism (Haff, Kirksey, & Stone). However Cr supplementation is not an effective
technique in the “treatment” of all muscle wasting diseases as Cr supplementation was
unable to improve the functional capacity in people inflicted with chronic progressive
external ophthalmoplegia or mitochondrial myopathy (Hespel, Eijnde, Van Leemputte,
Urso, Greenhaff, Labarque, et al., 2001; Klopstock, Querner, Schmidt, Gekeler, Walker,
Hartard, et al., 2000).
Research has also found Cr supplementation to enhance muscle size and strength
following disuse muscle atrophy leading Hespel et al. (2001) to suggest Cr can be
effective at preventing and or reversing neuromuscular degeneration in humans. In a
study examining the role of PCr and Cr in muscle metabolism Cr depleted rats
experienced atrophy in fast twitch-glycolytic muscle fibers (Meyer, Brown, Krilowicz, &
Kushmerick, 1986) followed by a study which found Cr supplementation to significantly
enhance protein content in rat muscle as a result of increases in myofibrillar proteins
(Flisinska-Bojanowska, 1996). These results suggest the consumption of Cr to promote
an increased rate of myofibular synthesis contributing to increases in lean body mass
(Haff, Kirksey, & Stone, 1999). Other studies have found Cr supplementation in
conjunction with resistance training to result in increases in lean body mass (Haff,
Kirksey, & Stone). An additional study examining in vitro supplementation of Cr in rats
found an increased synthesis rate of myosin heavy chains and actin when they are formed
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in vitro and in vivo (Haff, Kirksey, & Stone). Gyrate atrophy patients were also found to
have increased fast twitch-glycolytic muscle fiber diameter after consuming 1.5 g of Cr
per day for 1 year (Haff, Kirksey, & Stone; Sipila, Rapola, Simell, & Vannas, 1981).
Numerous studies have found Cr supplementation to positively influence the
health of people with heart problems (Andrews, Greenhaff, Curtis, Perry, & Cowley,
1998; Fagbemi, Kane, & Parratt, 1982; Gordon, Hultman, Kaijser, Kristjansson, Roll,
Nyquist, et al., 1995; Haff, Kirksey, & Stone, 1999; Hearse, Tanaka, Crome, & Manning,
1986; Robinson, Braimbridge, & Hearse, 1984; Pauletto & Stumia, 1996) and others
undergoing cardiac surgery (Pauletto & Stumia). Gordon et al. (1995) have found 1 week
of Cr supplementation to benefit chronic heart failure patients by improving muscular
strength and endurance. Another study involving chronic heart failure patients found PCr
to significantly improve left ventricular systolic and diastolic function (Pauletto &
Stumia) while other studies have found PCr to exert antiarrhythmic properties (Fagbemi,
Kane, & Parratt; Haff, Kirksy, & Stone; Hearse, Tanaka, Crome, & Manning, 1986). PCr
has been administered to people during cardiac surgery and because of PCr’s ability to
provide myocardial protection from acute ischemic injury and preoperative ischemic
damage as a treatment for acute myocardial infarction (Pauletto & Stumia). Some
researchers have even suggested that PCr be used in the treatment of chronic heart failure
patients (Andrews, Greenhaff, Curtis, Perry, & Cowley, 1998; Gordon et al., 1995; Haff,
Kirksey, & Stone). Cr also improves heart health indirectly as 56 days of Cr
supplementation was shown to improve blood lipid profiles by decreasing total
cholesterol and triglycerides in middle-aged males and females diagnosed as
hypertriglyceridemic (Earnest, Almada, & Mitchell, 1996). Additionally Kreider et al.
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(1998) found high density lipoproteins (HDL-C) to increase by 13% while very low
density lipoproteins (VLDL-C) to decrease by 13% in response to 28 days of Cr
supplementation.
Cr supplementation may also improve brain function as Norwood, Ingwall,
Norwood and Fossel (1983) found the CK/PCr system to be a rapidly available source of
ATP synthesis in the brain, suggesting CK to be a significant enzyme for energy
metabolism in the brain (Wallimann, Wyss, Brdiczka, Nicolay, & Eppenberger, 1992).
Moreover Cr supplementation at a dose of 5 g per day for 6 weeks has been shown to
enhance brain function in vegetarians by significantly improving intelligence test scores
requiring speed of processing such as the Raven’s Advanced Progressive Matrices and
working memory performance using a backward digit span test (Rae, Digney, McEwan,
& Bates, 2003).
Cr has also been shown to control the rate of actin and myosin biosynthesis, a
determinant of muscle hypertrophy (Walker, 1979). In 2003 Rawson and Volek
conducted a meta-analysis which cited a large variability in 1RM (repetition maximum)
bench press performance with improvements ranging from 3% to 45% among users of
Cr. Improvements in muscular endurance ranged from 16% to 43% and a negative
correlation was found between training status and strength increases aided by Cr
supplementation. A 45% increase in 1RM bench press performance was found in 19
untrained males (Vandenberghe, Goris, Van Hecke, Van Leemputte, Vangerven, &
Hespel, 1997) while a 30% increase was found in 14 males with approximately 6 years of
resistance training experience and a 6% increase was reported in 8 males with
approximately 11 years of resistance training experience (Rawson & Volek; Volek,
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Kramer, Bush, Boetes, Incledon, Clark, & Lynch, 1997). The negative correlation found
between Cr supplementation and strength increases is most likely a function of people
with more training experience being closer to their genetic potential, thus making it more
difficult to improve performance (Rawson & Volek). Another mechanism that may
explain the greater increase in weightlifting performance in untrained participants is that
most increases in strength during the first few weeks of weight training are due to
neuromuscular adaptations to exercise (Baechle & Earle, 2000). The possibility exists
that untrained individuals learned how to use the muscle they possessed more efficiently
rather than improving performance primarily through Cr consumption.
Another study compared 1RM strength gains in participants consuming Cr for a
duration of 4 weeks. The Cr plus training group improved bench press performance by
18% and leg press performance by 42%. While the Cr without training group improved
bench press performance by 8% and leg press performance by 16%, suggesting 40% of
the improvements in weightlifting performance were due to consuming a Cr supplement
independent of training (Arciero, Hannibal, Nindl, Gentile, Hamed, & Vukovich, 2001;
Rawson & Volek, 2003). Rawson and Volek (2003) suggest the 60% of unexplained
variance is most likely attributed to participants being able to train at higher workloads.
Although the mechanisms for performance enhancement are unknown, it has been
established that raising baseline Cr levels improves weightlifting performance (Rawson
& Volek).
Proposed Mechanisms of Improved Performance
Several hypotheses have been formulated to explain how Cr improves resistance
training performance. Possible mechanisms include an increase in lean body mass (Volek

43
et al., 1999), enhanced anticatabolic protection (Parise, Mihic, MacLennan, Yarasheski,
& Tarnopolsky, 2001), an increase in myosin heavy chain mRNA and protein expression
(Willoughby & Rosene, 2001), an alteration in the expression of myogenic transcription
factors (Hespel et al., 2001), increased protein synthesis (Rawson & Volek, 2003) an
increase in satellite cell mitotic activity (Dangott, Schultz, & Mozdziak, 2000), and or
increased intensity in individual workouts due to a greater supply of ATP (Casey,
Constantin-Teodosiu, Howell, Hultman, & Greenhaff, 1996; Rawson & Volek).
Parise, Mihic, MacLennan, Yarasheski and Tarnopolsky (2001) conducted a study
examining the effects of Cr supplementation leucine kinetics and mixed muscle-protein
synthesis in trained individuals. Male and female participants were randomly placed into
a control group who were supplemented with Cr at an initial dose of 20 grams of Cr per
day for five days followed by maintenance dose of 5 grams for 3-4 days or placebo group
who consumed an equivalent amount of a glucose polymer. Cr supplementation was
found increase muscle PCr and Cr levels in males and females but only reduced leucine
oxidation (19.6%) and plasma leucine rate of appearance (7.5%) in males; suggesting
short term Cr supplementation may provide anticatabolic protection for lean muscle
tissue in males and that tissues responding to the Cr supplementation or the signaling
response(s) to Cr supplementation may be gender specific. No significant differences
were found in whole body or mixed muscle protein synthesis (Praise, Mihic, MacLennan,
Yarasheski, & Tarnopolsky, 2001).
In 2001 Willoughby and Rosene conducted a 12 week study composed of 3
groups (control, placebo and Cr) to examine the effects of Cr supplementation and heavy
resistance training on muscle strength, myosin heavy chain (MHC) isoform mRNA and
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MHC protein expression. MHC mRNA expression was found to be significantly greater
in Type I, IIa and IIx muscle fibers in the Cr supplementation group than the placebo and
control groups. Moreover MHC protein expression was significantly greater in Type I
and IIx muscle fibers than the placebo and control groups; no significant difference was
found between the Cr and placebo groups in IIa fibers but each was significantly greater
than the control group (Willoughby and Rosene). Past research has found heavy
resistance training to enhance myofibrillar protein synthesis (Welle, Bhatt, & Thornton,
1999) and Cr supplementation appears to increase MHC and myofibrillar activity
enhancing the positive effects from heavy resistance training (Willoughby and Rosene).
The expression of myogenic transcription factors have been associated in the
regulation of muscle fiber adaptations that occur during muscle hypertrophy. Which lead
Hespel et al. (2001) to examine the effects of Cr supplementation on functional and
structural adaptations of skeletal muscle and the expression of myogenic transcription
factors during 2 weeks of leg immobilization, resulting in disuse atrophy, followed by an
exercise rehabilitation program in a double-blind trial involving 22 participants. Leg
immobilization resulted in a decrease in quadriceps muscle cross sectional area (CSA) by
approximately 10% and maximal knee extension power by approximately 25% in both
groups. During the 10 week recovery period the Cr supplementation group recovered at a
significantly faster rate than the placebo group in terms of CSA and maximal knee
extension power. The immobilization procedure did not result in myogenic factor protein
expression in either group; however, in the placebo group myogenin protein expression
was significantly increased while myogenic regulatory factor (MRF) MRF4 protein
expression was significantly increased in the Cr group. The increase in MRF4 was also
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positively correlated with the change in mean muscle fiber diameter. These results
suggest Cr supplementation promotes muscle hypertrophy during rehabilitative strength
training and the effect may be caused by a Cr induced increase in MRF4 and myogenin
expression (Hespel et al., 2001).
Satellite cell mitotic activity is vital in postnatal muscle growth and Cr
supplementation is the first oral nutritional supplement to result in enhanced satellite cell
mitotic activity (Dangott, Schultz, & Mozdziak, 1999). As muscles grow myofiber
hypertrophy occurs and increases in muscle fiber diameter result in increases in myofiber
nuclei. Myonuclei do not divide and satellite cells provide the new DNA for enlarging
myofibers by proliferating and when appropriate donate their nuclei to the enlarging
myofibers (Moss & Leblond, 1971; see also Dangott, Schultz, & Mozdziak). The
importance of satellite cells has been demonstrated in a prior study suggesting a decrease
in satellite cells contribution of nuclei to enlarging muscle fibers resulted in reduced
muscle growth (Mozdziak, Schultz, & Cassens, 1997). Other research has suggested
increased satellite cell mitotic activity is necessary to maintain a constant volume of
cytoplasm surrounding each myonucleus during an increase in muscle size (McCall et al.,
1998; Rosenblatt & Parry, 1993).
Dangott, Schultz, and Mozdziak (1999) conducted a study examining the effects
of Cr supplementation on compensatory hypertrophy and satellite cell mitotic activity in
rats. Results from this study suggest Cr supplementation in conjunction with increased
functional load results in significant increases satellite cell mitotic activity in overloaded
muscles. However, there was no significant increase in satellite cell mitotic activity in the
non-overloaded muscles. No significant differences were found in myofiber diameter in
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overloaded and non-overloaded plantaris muscles between the Cr supplemented and
control groups. This study suggests that Cr supplementation increases satellite cell
mitotic activity during compensatory hypertrophy in which Cr supplementation in
conjunction with increased functional capacity increases satellite cell mitotic activity
(Dangott, Schultz, & Mozdziak). Brannon, Adams, Coniff and Baldwin (1997) have
conducted a study suggesting that increased functional capacity of a muscle is necessary
for Cr supplementation to elicit a hypertrophic response in rats.
It must be noted that Cr supplemented rats had a higher increase in body mass and
had higher increases in muscle mass, myofiber diameter, and index of satellite cell
mitotic activity than the control group and the small sample size of 12 rats (6 in each
group) may account for the reason more significant differences were not found between
the groups. More significant differences may have been found but muscle fiber type
changes were introduced to the plantaris muscle of the rats in which myofibers may have
lost their fast phenotype and developed a slower phenotype during the study (Ianuzzo &
Chen, 1979; Noble, Tang, & Taylor, 1984; Roy, Talmadge, Fox, Lee, Ishihara, &
Edgerton, 1997) and other studies have found fast twitch muscle fibers to be more
responsive to Cr supplementation than slow twitch muscle fibers (Brannon, Adams,
Coniff, & Baldwin, 1997; Sipila, Rapoloa, Simell, & Vannas, 1981; Syrotuik & Bell,
2004).
As of 1999 it was unknown how Cr supplementation was related to increased
satellite cell mitotic activity, but a link does exist. Cr supplementation may increase Cr
levels within myofibers (Brannon, Adams, Coniff, & Baldwin, 1997; Casey, ConstantinTeodosiu, Howell, Hulman, & Greenhaff, 1996; Dangott, Schultz, & Mozdziak, 1999)
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which increases osmotic pressure on the myofibers (Dangott, Schultz, & Mozdziak) and
the increased osmotic pressure may lead to increases in muscle size (Brannon, Adams,
Coniff, & Baldwin). Increased osmotic pressure may indirectly initiate satellite cells to
proliferate and fuse with myofibers undergoing hypertrophy (Dangott, Schultz, &
Mozdziak). Dangott, Schultz and Mozdziak (1997) also suggest Cr supplementation
enhances muscle hypertrophy via a myofiber mechanism because satellite cell mitotic
activity is controlled by myofibers (Mozdziak, Truong, Macius, & Schulz, 1998).
Many studies suggest an increase in body mass from Cr supplementation, long
term studies ranging from 8 to 140 days suggest Cr can increase total body mass and fatfree mass (Haff, Kirksey, & Stone, 1999). Increases in body mass due to short-term Cr
supplementation are most likely explained by water retention, but Balsom, Soderlund,
Sjodin and Ekblom (1995) suggest that increased body mass resulting from long-term Cr
supplementation and a resistance training regime may result from increases in fast twitchglycolytic muscle fiber diameter, as long-term Cr supplementation stimulates an
increased myofibular protein synthesis rate. In support of Balsom et al’s. (1995) theory
numerous studies have suggested that Cr plays a critical role in protein synthesis, in
which Cr may be the chemical signal linking muscular activity and increased contractile
protein synthesis during hypertrophy (Haff, Kirksey, & Stone).
The majority of research has suggested Cr supplementation to improve
performance in high intensity, short duration bouts of exercise including sprint cycling
(Balsom, Ekblom, Soderlund, Sjodinm, & Hultman, 1993; Birch, Noble, & Greenhaff,
1994; Casey, Constantin-Teodosiu, Howell, Hultman, & Greenhaff, 1996; Prevost,
Nelson, & Morris, 1997; Syrotuik & Bell, 2004) and resistance training (Greenhaff,
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Bodin, Soderlund, & Hultman, 1994; Greenhaff, Casey, Short, Harris, Soderlund,
Hultman, 1993; Rawson & Volek, 2003; Volek et al., 1997) but other studies with similar
protocols have failed to yield significant performance improvements (Barnett, C., Hinds,
M., & Greenhaff, 1996; Cooke & Barnes, 1997; Febbraio, Flanagan, Snow, Zhio, &
Carey, 1995; Kilduff et al., 2002; Stevenson & Dudley, 2001; Syrotuik & Bell).
Methodological, procedural and or experimental design differences may account for the
equivocal results but Greenhaff, Bodin, Soderlund and Hultman (1994) have suggested
the effectiveness of Cr supplementation is dependent upon the extent of elevation
experienced in intracellular muscle Cr that occurs in each individual. Studies support this
claim by finding people with lower endogenous Cr levels (vegetarians) to experience
greater improvements in performance than people with higher endogenous Cr levels prior
to Cr supplementation (Burke, Chilibeck, Parise, Candow, Mahoney, & Tarnopolsky,
2003; Syrotuik & Bell).
There are three proposed interindividual responses to Cr supplementation:
responders (R), individuals who experience a > 20 mmol·kg-1 dw increase in total
intramuscular Cr and PCr (Greenhaff, Bodin, Soderlund, & Hultman, 1994; Syrotuik &
Bell); quasi responders (QR), individuals who experience between a 10-20 mmol·kg-1
dw increase (Syrotuik & Bell) and nonresponders (NR), individuals who experience < 10
mmol·kg-1 dw increase (Greenhaff, Bodin, Soderlund, & Hultman; Syrotuik & Bell).
Greenhaff, Bodin, Soderlund and Hultman (1994) suggest it may be necessary to
increase total muscle Cr by close to 20 mmol·kg-1 dry weight (dw) from Cr
supplementation to obtain significant performance improvements. Kilduff et al. (2002)
support Greenhaff et al’s. (1994) claim by noting significant performance improvements
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were not obtained in peak force or total work output during repeated isometric
contractions on bench press in their study as a result of having 4 nonresponders to Cr
supplementation in the subject pool. The nonresponders experienced increased Cr levels
of ≤ 21 mmol·kg-1 dw which may have obscured the overall group changes of the 32
participants in their study (Syrotuik & Bell, 2004).
People respond differently to stimuli such as resistance training programs and
ergogenic aids (Bouchard & Malina, 1986; Syrotuik & Bell, 2004; Willams, 1998)
furthermore genetic research supports the idea of having responders and nonresponders to
treatments (Syrotuik & Bell). Greenhaff, Bodin, Soderlund and Hultman (1994) suggest
approximately 20%-30% of individuals fall into the category of NR following 5 days of
Cr supplementation at a dose of 20 grams per which may account for the lack of
significant performance improvements in some studies particularly with small sample
sizes (Syrotuik & Bell).
Syrotuik and Bell (2004) conducted a study to determine the physiological profile
of R and NR to Cr supplementation. Participants consisted of 11 males who
supplemented with Cr for 5 days at a dosage of 0.3 g*kg-1*d-1. Of the 11 participants 3
were R, 5 were QR, and 3 were NR. There was a descending trend regarding muscle fiber
composition between the three groups. R had the highest percentage of type II fibers
(63.1%), followed by QR (45.5%) and NR (39.5%). R and QR had a greater muscle
cross-sectional area than NR pre and post Cr supplementation. R and QR had mean crosssectional areas for type I (1,509 and 1,270 υm2), type IIa (1,807 and 2,238 υm2) and type
IIb (1,695 and 1,740 υm2) compared to NR with type I (900 υm2), type IIa (1,377 υm2),
and type IIb (1,213 υm2). R had greater mean muscle fiber increases than NR, type I (320
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verse 60 υm2), type IIa (971 verse 46 υm2), and type IIb (840 verse 78 υm2). A
descending trend was also found in body mass and fat free mass between the groups. R
had the greatest increase in total body mass (2.4 kg) and fat free mass (2.0 kg), followed
by QR (2.1 kg and 1.9 kg) and NR (1.9 kg and 1.7 kg). R improved maximal leg press
performance by 25.8 kg followed by QR (2.5 kg) and NR (2.0 kg). The best determining
factors determining the effectiveness of Cr supplementation were muscle fiber
distribution and muscle CSA (Syrotuik & Bell).
Creatine Supplementation and Nutritional Choices
Nutritional choices also play a role in the effectiveness of Cr supplementation as
caffeine may negate some of the positive performance benefits received from Cr
supplementation (Vandenberghe, Gillis, Van Leemputte, Van Hecke, Vanstaple, &
Hespel, 1996). A study conducted by Vandenberghe et al. (1996) was composed of three
groups: a placebo group, a Cr group and a Cr plus caffeine group. The Cr and Cr plus
caffeine groups significantly increased intramuscular PCr concentrations, however only
the Cr group experienced significant improvements in dynamic torque production. In
1998 another study was published examining the effects of caffeine on Cr
supplementation and was composed of the same three groups: a placebo group, a Cr
group and a Cr plus caffeine group (Vanakoski, Kosunen, & Meririnne, 1998). As in the
Vandenberghe et al. (1996) study researchers found that caffeine had no effect on Cr
absorption, however researchers did not find any significant performance improvements
in any of the groups in anaerobic or aerobic performance. Anaerobic performance was
measured by maximal pedaling speed (rpm), maintenance of maximal speed (rpm) (or
total work output (kJ)) during 1 minute cycling bouts. Aerobic measurements were made
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by 45 minutes of cycling at a constant speed. No statistical differences were found
between the groups for heart rate or blood lactate during aerobic or anaerobic exercise.
Sample sizes in each study were small, 9 and 7 participants respectively.
Cr absorption rates are not affected by the consumption of caffeine so
theoretically performance improvements gained from Cr should not be affected by
caffeine, however no evidence exists to support this claim. In both studies Cr
supplementation in the caffeine plus Cr group failed to significantly improve
performance. Clearly more research needs to be conducted on this topic before a stance
can be taken of the effectiveness of Cr supplementation when consumed in conjunction
with caffeine.
Protein and carbohydrate consumption in conjunction with Cr supplementation
have been found to significantly affect Cr absorption rates, due to insulin release
(Steenge, Simpson, & Greenhaff, 2000). Numerous studies and books have reported
insulin release due to carbohydrate consumption (Green, Hultman, Macdonald, Sewell, &
Greenhaff, 1996; Steenge, Lambourne, Casey, Macdonald, & Greenhaff, 1998; Ivy &
Portman, 2004; Powers & Howely, 2004; Steenge, Simpson, & Greenhaff) and insulin
appears to aid Cr retention in response to Cr supplementation. Studies have shown
carbohydrate or a combination of carbohydrate and protein consumption in conjunction
with Cr supplementation to significantly enhance muscle Cr retention (Steenge, Simpson,
& Greenhaff) as insulin release at concentrations of approximately 100 mU/l or greater
can enhance Cr retention in human skeletal muscle (Steenge, Lambourne, Casey,
Macdonald, & Greenhaff, 1998). Cr retention rates have been shown to be enhanced by
approximately 25% (Steenge, Simpson, & Greenhaff) to 60% when a creatine
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supplement is consumed with an insulin releasing stimulus (Green, Hultman, Macdonald,
Sewell, & Greenhaff; Green, Simpson, Littlewood, Macdonald, & Greenhaff, 1996;
Steenge, Simpson, & Greenhaff). The wide variability in enhanced retention rates may be
due to functional differences between the studies in which urinary Cr analyses were
conducted at 40 and 24 hours respectively following consumption of a Cr supplement
(Steenge, Simpson, & Greenhaff).
Cr retention following supplementation varies among participants from no
retention to a recorded 40 mmol/kg dm increase (Green, Hultman, Macdonald, Sewell, &
Greenhaff, 1996; Greenhaff, 1996; Steenge, Simpson, & Greenhaff, 2000; See also
Greenhaff, Casey, Short, Harris, Souderlund, & Hultman, 1994; Harris, Soderlund, &
Hultman, 1992). Variables such as muscle fiber type (Syrotuik & Bell, 2004), age
(Rawson, Clarkson, Price, & Miles, 2002; Rawson & Clarkson, 1999), endogenous Cr
levels (Shrier, 2004) and insulin release affect absorption rates (Steenge, Simpson and
Greenhaff, 2000; Walker, 1979). Moreover individuals with similar pre-supplementation
Cr concentrations have been found to vary in Cr retention as much as six-fold (Steenge,
Simpson, & Greenhaff), however the consumption of carbohydrates in conjunction with
Cr supplementation has been found to reduce interindividual variability in the amount of
muscle Cr retention during supplementation. In one study all 12 participants experienced
an increase in muscle total creatine (TCr) of ≥ 20 mmol/kg dm which is equivalent to
responders of Cr supplementation (Syrotuik & Bell, 2004). The Steenge, Simpson and
Greenhaff study suggests a stimulatory effect of carbohydrates on muscle Cr retention
due to insulin release stimulating sodium-potassium pump activity (See also Haugland, &
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Chang, 1975). This research is consistent with animal based research that suggested
insulin to increase Cr absorption (Walker, 1979).
Steenge, Simpson and Greenhaff (2000) also found that consuming 50 g of
protein in conjunction with 47 g of carbohydrates is as effective as consuming 96 g of
carbohydrates at increasing Cr retention following Cr supplementation and is
significantly more effective at increasing Cr retention while consuming a Cr supplement
in conjunction with 5 g or 50 g of carbohydrates. The mechanism explaining this
phenomena is that even though glucose is the primary regulator of pancreatic insulin
release several proteins have been found to stimulate insulin secretion (Spiller, Jensen,
Pattison, Chuck, Whittam, & Scala, 1987; Steenge, Simpson, & Greenhaff) and the
consumption of proteins in conjunction with carbohydrates can result in greater increases
in serum insulin concentrations then would be expected from summing individual serum
insulin responses from the consumption of protein or carbohydrates independent of each
other (Steenge, Simpson, & Greenhaff). The results of the Steenge Simpson and
Greenhaff study suggest the consumption of protein in conjunction with carbohydrates
has an insulin-potentiating and blood glucose-moderating effect (Steenge, Simpson, &
Greenhaff), as insulin promotes the entrance of Pi into muscle tissue as a result of insulin
release (Green, Hultman, Macdonald, Sewell, & Greenhaff, 1996).
The effects of Cr retention from insulin release are reduced within 24 hours of the
initial consumption of a Cr supplement thus the longer a Cr supplement is consumed the
less effect insulin has on Cr retention (Steenge, Simpson, & Greenhaff, 2000). As a
whole Cr retention may diminish over time as the body nears maximal Cr storage
capacity (Rawson & Volek, 2003). However research has found the consumption of 5 g
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of Cr in conjunction with 94 g of carbohydrates four times a day over a period of 5 days
to increase total muscle Cr accumulation in participants by 62.7% over the amount of Cr
retained in participants who consumed a Cr supplement without carbohydrates (Green,
Hultman, Macdonald, Sewell, & Greenhaff, 1996).
Insulin, insulin-like growth factor I, triiodothyronine and amylin have also been
shown to stimulate sodium-potassium ATPase pump activity enhancing Cr transport in
muscle cells (Persky & Brazeau, 2001; Steenge, Simpson, & Greenhaff, 2000). Cr
primarily enters muscles by binding to a specific transporter protein and is transported
into muscles against a high-concentration gradient (Guerrero-Onriveros & Wallimann,
1998; Steenge, Simpson, & Greenhaff). However the amount of Cr transporter protein
may be reduced when the body is exposed to prolonged periods of high plasma Cr
concentrations, as such transporter proteins may serve as a regulator of muscle Cr content
(Steenge, Simpson, & Greenhaff). Studies have also suggested that a slowing of muscle
Cr accumulation and or transport occurs in comparable amounts with an increase in
muscle Cr stores (Harris, Soderlund, & Hultman, 1992; Loike, Zalutsky, Kaback,
Miranda, & Silverstein, 1988). Additionally sodium-potassium pump inhibition has been
found to occur during prolonged periods of high plasma Cr concentrations resulting in
inhibition of cellular Cr transport into muscle tissue, an expected response because Cr
transport into muscle is sodium dependent (Steenge, Simpson, & Greenhaff).
Population Differences Effect Creatine Supplementation
Cr absorption in response to supplementation is also affected by population
characteristics. Vegetarians have lower endogenous Cr levels and have been found to
benefit more from Cr supplementation than individuals who regularly consume meat
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(Shrier, 2004). The elderly population (> 68 years) have also been found to possess lower
endogenous Cr levels than the younger population (Rawson, Clarkson, Price, & Miles,
2002; Rawson & Clarkson, 2000). The elderly may have lower endogenous Cr levels
because of lower levels of dietary Cr consumption.
Differences in Cr absorption rates have also been observed between young and
old subjects (> 60 years) in which younger populations are better able to absorb Cr than
older populations (Rawson & Clarkson, 1999; Rawson, Clarkson, Price, & Miles 2002).
Older populations may also become less efficient at storing Cr because of decreased Cr
absorption in the gut, less proficient Cr transport in the blood and or less effective muscle
Cr uptake (Rawson, Clarkson, Price, & Miles). Therefore older individuals may require
longer supplementation periods or may need to consume higher doses of Cr to reach
saturation levels in muscles (Rawson & Clarkson). Cr supplementation has been found
effective at increasing performance in the elderly but results are not as impressive as what
has been found in younger populations (Rawson & Clarkson).
Concerns of Consuming a Supplement
In accordance with the Dietary Supplement Health and Education Act (DSHEA) of
1994 the Food and Drug Administration (FDA) is no longer responsible for regulating the
effectiveness or safety of dietary supplements (Congeni & Miller, 2002). A dietary
supplement is defined as a product taken by mouth that contains a “dietary ingredient”
intended to supplement the diet. Dietary ingredients can include vitamins, minerals,
herbs, other botanicals, amino acids, and substrates such as enzymes, organ tissues,
glandulars and metabolites. Under the DSHEA bill the law does not require
manufacturers and/or distributors of supplements to investigate or forward reports they
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receive of injuries or illnesses that may be related to the use of their products to the FDA.
Moreover the FDA cannot remove a supplement from the market until they provide
evidence suggesting the supplement is unsafe (U.S. Food and Drug Administration,
2001).
Under current regulations the FDA does not ensure supplements contain the
ingredients manufacturers place on the label and as of 2001 the FDA had not established
a minimum standard of practice for supplement manufacturers (U.S. Food and Drug
Administration, 2001). Manufacturers must only provide evidence to the FDA suggesting
a supplement is reasonably safe before introducing the product to the market.
Additionally no evidence must be presented to the FDA suggesting the safety of a
supplement if the dietary ingredient(s) is found in foods or the ingredient(s) was
marketed before October 15, 1994 (U.S. Food and Drug Administration, 2001); Cr falls
under each of these categories. It is also important to note the FDA does not regulate
serving size or amount of a nutrient in a supplement (U.S. Food and Drug
Administration, 2001). As a result most companies suggest a loading phase of consuming
20-25 grams of Cr a day for a period of 4 to 5 days followed by a maintenance dosage of
5 grams a day (Juhn, 1999). A loading phase of 10 grams a day for 4 days has been
shown to sufficiently load the body with Cr and a maintenance phase of 2 g or more
specifically 0.03 g/kg of body weight per day is enough to maintain maximal muscle Cr
concentration (Juhn, O’Kane, & Vinci, 1999). Research has also found the loading phase
of Cr supplementation to be unnecessary as supplementation with 0.3 g*kg-1*d-1 for a 5
day period has been found to elevate muscle total Cr and PCr by 10-25% (Syrotuik &
Bell, 2004).
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Possible Negative Effects of Creatine Supplementation
As of 1999 the FDA officially logged 32 complaints regarding Cr
supplementation including seizure, cardiac arrhythmia, cardiomyopathy, deep venous
thrombosis, rhabdomyolysis and death. However, no conclusions have been made linking
the complaints in these reports to Cr supplementation (Juhn, O’Kane, & Vinci, 1999),
moreover most research conducted on Cr supplementation has no reported adverse side
effects except weight gain viewed as a negative (Juan, 1999). In 1999 Haff, Kirksey and
Stone reported that 80 research articles in peer-reviewed journals and approximately 70
papers presented at professional conferences only one demonstrated the occurrence of
side effects from Cr supplementation.
Despite accumulating evidence suggesting the safety of short term Cr
supplementation the media has reported anecdotal claims suggesting Cr supplementation
can increase the occurrence of muscle cramps, muscle strains, increase renal stress and
cause liver damage. An apparent fallacy of Cr supplementation is that individuals who
consume Cr and train in hot and humid climates experience an increased likelihood of
muscle cramps. A study by Williams and Brach (1998) suggests that Cr supplementation
results in a fluid balance shift where more water enters muscle cells which could
theoretically alter electrolyte balance, promote dehydration and possibly increase thermal
stress. However a study by Kilduff et al. (2004) provides evidence contradictory to this
hypothesis. Participants consisted of 21 endurance trained males who performed two tests
to exhaustion at 63 +/- 5% of VO2 max. During the first trial participants were not given
any supplements. For 7 days before the second trial participants consumed either 20 g a
day of a Cr supplement or a placebo and exercised in a hot environment (30.3 +/- 0.5 C).
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As a whole Cr supplementation did not significantly improve performance, but did
increase intracellular water and reduced thermoregulatory and cardiovascular responses
by decreasing heart rate, rectal temperature and sweat rate compared to the placebo
group. Additionally participants identified as responders significantly improved time to
exhaustion.
Haff, Kirksey and Stone (1999) found no data from scientific literature suggesting
that muscle cramping occurs with Cr supplementation. In a study examining the effects of
Cr supplementation during training and the incidence of muscle cramping, injuries, and
gastrointestinal distress on 164 athletes of which 80 consumed a Cr supplement. No
injuries or muscle cramping were reported during the study (Kreider, Rasmussen,
Ransom, & Almada, 1998). Moreover in a 3.5 year retrospective study on the long term
health effects of Cr supplementation there were no reported incidence of muscle
cramping from any participants (Schilling, Fry, Kearney, Smith, O’Bryant, Utter, et al.,
1998). The current literature on Cr supplementation does not support the claim that Cr
supplementation increases the likelihood of muscle cramps (Haff, Kirksey, & Stone).
Another concern is that Cr supplementation may increase renal stress and possibly
damage the liver as high protein diets have been shown to impair kidney function. The
ingestion of a high protein meal or a solution of amino acids can increase renal blood
flow and the glomerular filtration rate (GFR) by up to 20%, placing added stress on the
kidneys (Culpepper, 1998). Animal models of renal injury suggest that high protein diets
increase proteinuria which slows the decline in the GFR (Culpepper). As of 1998 it was
unknown if Cr supplementation as a result of amino acid metabolism could produce
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similar effects (Culpepper) but the only link of Cr supplementation and renal stress has
been reported in a male with pre-existing liver failure (Pritchard & Kalra, 1998).
In 1998, the Lancet published a case study of a 25 year old male with focal segmental
glomerulosclerosis and frequently relapsing steroid-responsive nephritic syndrome who
experienced an adverse side effect to Cr supplementation. The patient had been
consuming a Cr supplement at the suggested dose for 7 weeks and during this period
doctors diagnosed him with renal dysfunction. Upon advice from his doctors the male
stopped using the Cr supplement and his kidneys began to function properly. Results
from this study provide researchers with strong evidence that Cr supplementation was
responsible for renal dysfunction in this case (Pritchard & Kalra, 1998). However, Haff,
Kirksey and Stone (1999) identified several clinical studies (Alamada, Mitchell, &
Earnest, 1996; Earnest, Alamada, & Mitchell, 1996; Poortmans, Auquier, Renaut,
Durussel, Saugy, & Brisson, 1997; Poortmans & Francaux, 1998) that have not shown Cr
to negatively affect liver or kidney function. Additionally Poortmans and Francaux
(1998) found Cr supplementation to have no effect on markers of renal stress. In a 3.5
year retrospective study on Cr supplementation researchers reported no increases in
markers of renal stress (Schilling et al., 1998). The current body of literature suggests
there is no significant increase in renal stress when a Cr supplement is consumed at the
suggested dosage for up to 3.5 years.
The last concern from the media surrounding Cr supplementation involves the
possible long term side effects. Research is not widely available on the long term effects
of Cr supplementation but Cr has been prescribed as a long term treatment for medical
conditions in which no side effects have been reported (Sipila, Rapola, Simell, & Vannas,
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1981; See also Haff, Kirksey, & Stone; 1999). Cr has been administered to participants
with gyrate atrophy of the choroids and retina daily at a dose of 1.5 g per day for 1 year
(Sipila, Rapola, Simell, & Vannas). Cr has also been sold as a sport supplement since the
1980’s and no apparent long term side effects have surfaced, but more research is needed
before scientists can proclaim the long term use of Cr supplements as safe.
There was a concern in the scientific community involving the effects of Cr
supplementation on blood pressure, because Cr is an osmotically active substance it
raises the amount of water present in muscle cells which increases intracellular water and
blood volume which may result in increased blood pressure. Peeters, Lantz and Mayhew
(1999) examined the effects of Cr supplementation on blood pressure over a 6 week
period in 34 strength trained males (20 Cr supplementation: 11 CrM, 9 CrP and 14
placebo) and found no significant changes in blood pressure.
A valid concern surrounding Cr supplementation is that endogenous Cr production is
suppressed during the course of supplementation. However, in two studies conducted by
Walker endogenous Cr production resumed following cessation of Cr supplementation
(Walker, 1960; Walker, 1979; See also Haff, Kirksey, & Stone; 1999). More research
needs to be conducted involving the effects of Cr supplementation on the biosynthesis of
endogenous Cr production particularly in the long term with an emphasis placed on new
steady-state relations that may occur between creatinine and Cr during periods of
prolonged supplementation (Culpepper, 1998).
Cr appears to be safe when cycled with periods of consumption and
non-consumption. The most common short term side effects of Cr supplementation that
have been reported are diarrhea, muscle cramps, dehydration and weight gain viewed as a
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negative effect. In one study involving 52 male collegiate athletes (28 football and 24
baseball players) side effects were self reported as follows: 16 diarrhea, 13 muscle
cramps, although only two athletes reported experiencing a sprain or muscle tear, 7
experienced weight gain viewed as a negative, 7 reported dehydration, 12 reported other
effects and 14 reported no negative side effects. It must be noted 39 participants exceeded
the recommended maintenance dose of 2 g to 5 g per day with the most common
maintenance dose being 6 g to 8 g per day; while 18 participants consumed 9 g or more
per day and 18 participants consumed 17 g to 20 g per day as a maintenance dose.
Despite the reported side effects, 40 athletes (77%) reported they plan to continue using
Cr or plan on using Cr in the future (Juhn, O’Kane, & Vinci, 1999).
In a similar study on the perceived effects of Cr supplementation on division I
collegiate athletes similar results were found. Of the 219 athletes surveyed 90 athletes
(41%) reported using a Cr supplement and 80 athletes (89%) reported perceived positive
effects while 34 athletes (38%) reported perceived negative side effects and 10 athletes
(11%) reported no effects. It is important to note every athlete who reported a perceived
negative effect of Cr supplementation also reported a positive effect. In each group there
was a trend to use a lower than recommended loading phase dose and a higher than
recommended maintenance phase dose suggesting there is a need to education athletes on
the proper use of Cr supplementation (Greenwood, Farris, Kreider, Greenwood, & Byars,
2000).
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COLLEGE OF COLLEGE OF HEALTH AND HUMAN SCIENCES
DEPARTMENT OF JIANN-PING HSU SCHOOL OF PUBLIC HEALTH

INFORMED CONSENT
I understand that study I am about to participate in part of a research project
entitled The Relationship between Endogenous Creatine Levels, Maximal Upper
Body Strength, Body Fat and Short-Term Muscle Recovery in Males, conducted
by Vinny Dalbo (912-871-1991), a graduate student at Georgia Southern
University. The purpose of this study is to examine if endogenous (naturally
occurring) creatine levels present in the human body can influence indices of
athletic performance and general health.
Participation in this research study requires two meetings with the
experimenter over a four day period. Participation will include completion of a
three day food diary and a demographic questionnaire during the first meeting.
The second meeting requires a blood test of less than 10 mL of blood, an eight
hour fast, measurement of height, weight, and body fat percentage (using the
Jackson-Pollack 3-site skin fold assessment). Participants will also be asked to
complete a one repetition maximum bench press test, and five repeated maximal
effort bench press lifts with 80% of the participant’s one repetition maximum,
with two minute rest intervals between sets.
It is not believed nor are the three day food diary or demographic
questionnaire intended to cause any psychological discomfort to any participant.
Minimal amounts of physical discomfort may be experienced during the blood

85
test, which will be conducted by a licensed phlebotomist and the exercise portion
of the test. Participants will be asked to exert maximal effort during the one
repetition maximum test and the muscle recovery portion of the test. Discomfort
experienced from lifts should be minimal as participants should have at least one
year weight training experience and should be accustom to weight training. “I
understand that medical care is available in the event of injury resulting from
research but that neither financial compensation nor free medical treatment is
provided. I also understand that I am not waiving any rights that I may have
against the University for injury resulting from negligence of the University or
investigators.” For those who wish to seek assistance following completion of the
study may contact Vinny Dalbo (912-871-1991), the Counseling Center (912-6815541) and or Health Services.
I understand that any relationship between myself and the information I
contribute to this study will be kept confidential. I understand that I may stop
answering any question at any time without prejudice to myself, course grade,
employment status or any other personal matter. For students in which extra credit
is offered for completion of the study, I understand that by answering all of the
questions in the assessment and completing the physical aspect of the test, I may
be able to receive extra credit to my final numerical grade. I understand that if I
do terminate the study, I will not receive extra credit, but will be allowed to
complete the compensatory extra credit assignment.
As a participant you have the right to ask questions and have those questions
answered. If you have questions about this study, please contact Vinny Dalbo
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(912-871-1991) or Dr. Jim McMillan (912-871-1926). For questions concerning
your rights as a research participant, contact Georgia Southern University Office
of Research Services and Sponsored Programs (912-486-7758).
No monetary compensation is offered for participation in this study and
participation is voluntary. You the participant are in no way required to
participate in this study and may end your participation at any time by telling the
person in charge or not returning the questionnaires. You also reserve the right to
not answer any question(s) you do not want to answer. You may chose to not
participate, stop participation, and or not answer any question(s) without penalty.
You must be 18 years of age or older to consent to participate in this research
study. If you consent to participate in this research study and to the terms above,
please sign your name and indicate the date below. You will be given a copy of
this consent form to keep for your records.

Title of Project: The Relationship between Endogenous Creatine Levels, Maximal Upper
Body Strength, Body Fat, and Short Term Muscle Recovery in Males
Principal Investigator: Vinny Dalbo, 2218 Hanner Field House, telephone: 912-871-1991,
vincent_j_dalbo@GeorgiaSouthern.edu
Faculty Advisor: Dr. Jim McMillan, Hollis Building, 912-871-1926,
jmcmillan@GeorgiaSouthern.edu

______________________________________
Participant Signature

_____________________
Date

I, the undersigned, verify that the above informed consent procedure has been followed.
______________________________________
Investigator Signature

_____________________
Date
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APPENDIX D: THREE DAY FOOD DIARY
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Name:

Day 1 (Use the back of the sheet if needed.)
Food Type (Include
Drinks)
Include brand and
names (eg. Kellogg’s
Oatbran cereal, KFC
chicken wings Ocean
Spray Cranberry
Juice)

Food Preparation
(Ingredient list, type of
preparation: baked or
fried, etc)

Serving Size/number of
servings
(include ounces, fluid
ounces, milli – liters,
cups, teaspoons, etc)

Breakfast

Lunch

Dinner

Snacks

Maintain a 3-day food record on three consecutive days. Be sure to include extras (i.e.
– sugar in tea, cream in coffee, butter on popcorn, etc.) when recording your intake.
Estimate the amount to the nearest common household measure such as teaspoon, cup or
ounces. Please ensure your records are accurate as possible.
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Name:

Day 2 (Use the back of the sheet if needed.)
Food Type (Include
Drinks)
Include brand and
names (eg. Kellogg’s
Oatbran cereal, KFC
chicken wings Ocean
Spray Cranberry
Juice)

Food Preparation
(Ingredient list, type of
preparation: baked or
fried, etc)

Serving Size/number of
servings
(include ounces, fluid
ounces, milli – liters,
cups, teaspoons, etc)

Breakfast

Lunch

Dinner

Snacks

Maintain a 3-day food record on three consecutive days. Be sure to include extras (i.e.
– sugar in tea, cream in coffee, butter on popcorn, etc.) when recording your intake.
Estimate the amount to the nearest common household measure such as teaspoon, cup or
ounces. Please ensure your records are accurate as possible.
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Name:

Day 3 (Use the back of the sheet if needed.)
Food Type (Include
Drinks)
Include brand and
names (eg. Kellogg’s
Oatbran cereal, KFC
chicken wings Ocean
Spray Cranberry
Juice)

Food Preparation
(Ingredient list, type of
preparation: baked or
fried, etc)

Serving Size/number of
servings
(include ounces, fluid
ounces, milli – liters,
cups, teaspoons, etc)

Breakfast

Lunch

Dinner

Snacks

Maintain a 3-day food record on three consecutive days. Be sure to include extras (i.e.
– sugar in tea, cream in coffee, butter on popcorn, etc.) when recording your intake.
Estimate the amount to the nearest common household measure such as teaspoon, cup or
ounces. Please ensure your records are accurate as possible.
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APPENDIX E: DEMOGRAPHIC QUESTIONNAIRE
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Demographic Questionnaire
ID# _________
Section I
1. Age (in years): ______________
2. Gender - Male
3. How many years have you been weight training: _________
4. Are you currently on a weight training regimen? Yes

No

If yes answer questions 5, 6, 7, 8
If no answer question 9

5. What type of rep ranges are you training with most frequently (circle the response that
most applies)?
High weight low reps

Moderate weight and reps

(1-8 reps)

(8-12 reps)

Low weight high reps
(12 or more reps)

6. What is the average break (rest period) you take between sets in minutes? __________
7. How many days per week do you currently lift weights?
1

2

3

4

5

6

7

8. Have you consistently been lifting weights 3 or more days per week for the last 30
days?
Yes

No
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9. How many months have passed since you consistently lifted weights 3 or more days
per week for 30 days? _________

Section II
1. Have you ever consumed a sport supplement? Yes

No

2. Have you ever consumed a supplement containing creatine? Yes

No

3. Have you consumed a sport supplement in the past 2 months?

No

Yes

4. If yes what supplement(s)?
_____________________________________________________

5. Have you consumed a supplement containing creatine in the past 4 months? Yes

No

If yes what supplement(s)?
_______________________________________________________

6. When was the last time you consumed a sport supplement (answer in months)?
________________________________________________________________________

7. What was the last sport supplement you consumed?
________________________________________________________________________

8. On average how many days per week do you weight train?
1

2

3

4

5

6

7
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9. On average how many days per week do you exercise?
1

2

3

4

5

6

7

10. Are you a hemophiliac? (trouble stopping bleeding) Yes
11. Do you have diabetes?

Yes

No

No

12. Do you have any liver problems? Yes

No

13. If yes, what problems do you have:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
14. Do you have any kidney problems?

Yes

No

15. If yes, what problems do you have:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
16. Do you have any blood born illnesses?

Yes

No
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DATA SHEET
ID # ____________

Height ________________

Weight ________________

Skin fold measurements
First

Second

Third

Average

Chest
Abdomen
Thigh

1RM _______________________

Set #
1
2
3
4
5

80% 1RM ___________________

# of Reps

96
APPENDIX F: NSCA BENCH PRESS STANDARDS
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Proper Bench Press and Spotting Technique
Beginning Position: Athlete
Starting position: Assume supine position on a bench in a five-point body contact
position. Place body on bench so that eyes are below the edge of the supports. Grasp the
bar with a closed pronated grip. Grip should be slightly wider than shoulder-width. Signal
the spotter for assistance in moving the bar off the supports. Place the bar over the chest
with elbows fully extended. All subsequent repetitions begin from this position.

Downward Movement Phase: Athlete
Lower the bar to touch the chest at approximately nipple level. Keep the wrists ridged
and directly above the elbows. Maintain the five-point body contact position.

Upward Movement Phase: Athlete
Push the bar upward until the elbows are fully extended. Keeps wrists ridged and directly
above the elbows. Maintain five-point body contact position. Do not arch back or raise
chest to meet the bar. After the set is completed, signal the spotter for assistance in
racking the bar. Keep a grip on the bar until it is racked.

Beginning Position: Spotter
Stand erect and very close to the head of the bench. Place feet should-width apart with
knees slightly flexed. Grasp the bar with a closed, alternated grip inside the athlete’s
hands. At athlete’s signal, assist in moving the bar off the supports. Guide the bar to a
position over the athlete’s chest. Release the bar smoothly.
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Downward Movement Phase: Spotter
Keep hands in the alternated grip position close to-but not touching-the bar as it
descends. Slightly flex the knees, hips, and torso and deep the back flat when following
the bar.

Upward Movement Phase: Spotter
Keep the hands in the alternated grip position close to-but not touching-the bar as it
ascends. Slightly extend the knees, hips, and torso and keep the back flat when following
the bar. At the athlete’s signal after the set is completed, grasp the bar with an alternated
grip inside the athlete’s hands. Guide the bar back onto the supports. Keep a grip on the
bar until it is racked.

Note. From Essential of strength training and conditioning (2nd ed.) (p.359), by T. R.
Baechle and R. W. Earle, 2000, Champaign: National Strength and Conditioning
Association.
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APPENDIX G: JACKSON POLLACK 3-SITE SKINFOLD EQUATION
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Jackson Pollock 3-Site Skin Fold Equation

Male 3-Site Equation (SUM3 = chest, abdomen, thigh)
Db = 1.10938 - (0.0008267 * SUM3) + (0.0000016 * SUM32) - (0.000257 * AGE)
%BF = [(4.57/ Db) - 4.142] * 100

Body Density
Black Male Age 19-45 = (4.86)/Db – 4.39
White Male Age 17-19 = (4.99)/Db – 4.55
White Male Age 20-80 = (4.95)/Db – 4.50

Jackson, A.S., & M.L. Pollack. Practical Assessment of body composition. Physician
Sport Medicine, 13:76-90, 1985. (As published in: Nieman DC: The Sports
Medicine Fitness Course. Bull Publishers. Palo Alto, 1986, pp. 101.
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APPENDIX H: NSCA ONE REPETITION MAXIMUM BENCH PRESS PROTOCOL
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NSCA One Repetition Maximum Bench Press Protocol
Equipment
•

Olympic-style weightlifting set with enough total weight to accommodate the
maximum lift of the strongest athlete and a variety of plate sizes to allow for 5-lb
gradations in weight.

•

A sturdy bench-press bench with integral bar rack of adjustable height.

Procedure
1. Instruct the athlete to warm-up with a light resistance that easily allows 510 repetitions.
2. Provide a 1-minute rest period.
3. Estimate a warm-up load that will allow the athlete to complete 3-5
repetitions by adding
•

10-20 lb or 5-10%

4. Provide a 2-minute rest period.
5. Estimate a conservative, near-maximum load that will allow the athlete to
complete 2-3 repetitions by adding
•

10-20 lb or 5-10%

6. Provide a 2 to 4-minute rest period.
7. Make a load increase
•

10-20 lb or 5-10%

8. Instruct the athlete to attempt a one repetition maximum lift.
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9. If the athlete was successful, provide a 2 to 4-minute rest period and go
back to step 7.
If the athlete failed, provide a 2 to 4-minute rest period, decrease the load
by subtracting
•

5-10 lb or 2.5-5%

AND then go back to step 8.

Continue increasing or decreasing the load until the athlete can complete
one repetition with proper exercise technique. Ideally, the athlete’s one
repetition maximum will be measured within five testing sets.

Note. From Essential of strength training and conditioning (2nd ed.) (p.409), by T. R.
Baechle and R. W. Earle, 2000, Champaign: National Strength and Conditioning
Association.
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APPENDIX I: EXTENDED CREATININE ANALYSIS
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Extended Creatinine Analysis
The first step of data analysis required making the 8 standards by combing
progressively greater amounts of the creatine standard with progressively fewer amounts
of HPLC-grade water in each of the 8 standard test tubes. Each of the 8 standards was
placed pipetted into 2 empty wells on a 96 well plate along with the creatinine samples.
Initial and final absorbance values were recorded at 492 nm on a plate reader. The final
absorbance was subtracted from the initial absorbance on each of the 8 standards yielding
the adjusted absorbance. The adjusted absorbance values for each standard was plotted
and fitted with a trend line yielding the creatinine standard curve (see Figure 2)
The next step was to subtract the final absorbance values from the initial
absorbance values to determine the adjusted absorbance value for each creatinine sample.
The adjusted absorbance values for each creatinine sample were plugged into the formula
seen in Figure 3 yielding the creatine values in mg/dl for each participant.

Figure I1. Creatinine standard curve
________________________________________________________________________
y = 0.0406x – 0.0016
r2 = 0.9993
______________________________________________________________________
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Figure I2. Creatinine determination formula
_______________________________________________________________________
Creatinine (mg/dl) = ((sample absorbance – y intercept) / slope)
______________________________________________________________________
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